Aston Pharmacy School, College of Health and Life Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK.
Syst Rev. 2022 May 11;11(1):88. doi: 10.1186/s13643-022-01933-4.
Rising demand for healthcare continues to impact all sectors of the health service. As a result of the growing ageing population and the burden of chronic disease, healthcare has become more complex, and the need for more efficient management of specialist medication across the healthcare interface is of paramount importance. With the rising number of pharmacists working in primary care in clinical roles, is this a role that pharmacists could support to ensure the successful execution of shared care agreement (SCA) in primary care for these patients?
Systematic review to identify activities and assess the interventions provided by pharmacists in primary care on SCA provision and how it affects health-related quality of life (HRQoL) for patients.
Primary studies in English which tested the intervention or obtained views of stakeholders related to pharmacist input to shared care agreement within primary care were included. The following electronic databases were systematically searched from the date of inception to November 2021: AMED®, CINAHL®, Cochrane Database of Systematic Reviews (CDSR), EMBASE®, EMCARE®, Google Scholar, HMIC®, MEDLINE®, PsycINFO®, Scopus and Web of Science®. Grey literature sources were also searched. The search was adapted according to the respective database-specific search tools. It was searched using a combination of Medical Subject Heading terms (MeSH), free-text search terms and Boolean operators.
A total of 5244 titles/abstracts were screened after duplicates were removed, and 64 full articles were assessed for eligibility. On examination of full text, no studies met the inclusion criteria for this review.
This review highlights the need for further research to evaluate how pharmacists in general practice can support the safe and effective integration of specialist medication in primary care with the use of SCA.
NIHR PROSPERO No: 2020 CRD42020165363 .
医疗保健需求的不断增长继续影响着卫生服务的各个部门。由于人口老龄化和慢性病负担的增加，医疗保健变得更加复杂，因此，在医疗保健界面上更有效地管理专科药物的需求至关重要。随着越来越多的药剂师在初级保健中担任临床角色，药剂师是否可以支持这一角色，以确保这些患者在初级保健中成功执行共同护理协议（SCA）？
系统评价旨在确定药剂师在初级保健中提供 SCA 方面的活动和干预措施，并评估其对患者健康相关生活质量（HRQoL）的影响。
纳入了以英语发表的、测试干预措施或获取与初级保健中药剂师对共同护理协议投入相关的利益攸关者观点的研究。从成立日期到 2021 年 11 月，系统地在以下电子数据库中进行了搜索：AMED®、CINAHL®、Cochrane 系统评价数据库（CDSR）、EMBASE®、EMCARE®、Google Scholar、HMIC®、MEDLINE®、PsycINFO®、Scopus 和 Web of Science®。还搜索了灰色文献来源。根据各自数据库的特定搜索工具对搜索进行了调整。它使用医学主题词（MeSH）、自由文本搜索词和布尔运算符的组合进行搜索。
在去除重复项后，共筛选了 5244 个标题/摘要，然后评估了 64 篇全文文章的资格。在检查全文时，没有研究符合本综述的纳入标准。
本综述强调需要进一步研究，以评估一般实践中的药剂师如何支持使用 SCA 在初级保健中安全有效地整合专科药物。
NIHR PROSPERO 编号：2020 CRD42020165363。
